share_log

SleepX Has Started Marketing Its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback

SleepX Has Started Marketing Its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback

SleepX已开始销售其旗舰产品DreamIt,这是一款基于人工智能的腕带,可通过生物反馈治疗打鼾问题
Accesswire ·  2022/11/30 02:00

In the first phase, DreamIT will be available to Android users and delivery of the first devices to customers is expected by the end of the year.

在第一阶段, DreamIt 将向Android用户开放,首批设备预计将在今年年底之前交付给客户。

GAN YAVNE, ISRAEL / ACCESSWIRE / November 29, 2022 / SleepX, a subsidiary of AppYea Inc. (OTC:APYP), which focuses on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, has announced that it has completed the tests of the initial version of the product and plans for production of up to 20,000 units per month.

GAN YAVNE,ISRAEL /ACCESSWIRE /2022 年 11 月 29 日/AppYea Inc. 的子公司 SleepX (场外:APYP),哪个 专注于开发用于治疗睡眠呼吸暂停和打鼾的精确可穿戴监测解决方案,宣布已完成该产品初始版本的测试,并计划每月生产多达20,000台。

The price of DreamIT for the consumer will be $149, and until the Christmas holidays, they can purchase it at a 33% discount at a sale price of only $99.

消费者购买的DreamIt的价格为149美元,在圣诞节假期之前,他们可以以33%的折扣购买,销售价格仅为99美元。

A non-intrusive, stylish wristband, DreamIT uses a combined vibration motor and sensor system to measure real-time physiological data, including pulse, blood oxygen level, blood pressure, etc. The data from the wristband is recorded in the SleepX phone app for analysis and storage.

DreamIt 是一款非侵入性、时尚的腕带,它使用组合的振动马达和传感器系统来测量实时生理数据,包括脉搏、血氧水平、血压等。来自腕带的数据记录在 SleepX 手机应用程序中,用于分析和存储。

After our proprietary algorithms properly analyze all data in real-time, the app activates the vibration mechanism on the wristband with the right intensity and for the needed duration. The gentle vibration trains your brain to breathe correctly.

在我们的专有算法正确地实时分析所有数据之后,该应用程序会以适当的强度和所需的持续时间激活腕带上的振动机制。轻柔的振动可以训练你的大脑正确呼吸。

Over time, your brain and body use biofeedback to teach themselves how to sleep in the correct position and proper breathing technique, leading to improved night breathing.

随着时间的推移,你的大脑和身体会使用生物反馈来自学如何以正确的姿势和正确的呼吸技巧入睡,从而改善夜间呼吸。

Users can also receive comprehensive statistical reports on their sleep quality and health. Likewise, the app sends alerts about critical health changes requiring medical consultation and follow-up.

用户还可以收到有关其睡眠质量和健康状况的全面统计报告。同样,该应用程序会发送有关需要医疗咨询和随访的关键健康变化的警报。

DreamIT's marketing strategy, in addition to online marketing, includes entering Amazon and working with distributors. The company is in discussions with a large Telecom company from Western Europe, a pharmacy chain store and leading mattress manufacturers.

除了在线营销外,DreamIt的营销策略还包括进入亚马逊和与分销商合作。该公司正在与西欧的一家大型电信公司、一家药房连锁店和领先的床垫制造商进行讨论。

In addition, because in recent months, huge companies are entering the field of breathing monitoring during sleep, the company plans to contact leading smartphone manufacturers in the world to offer the assimilation of its technology and rights to use its unique patent portfolio, which continues to grow.

此外,由于最近几个月,大公司正在进入睡眠期间呼吸监测领域,因此该公司计划联系全球领先的智能手机制造商,以提供其技术和使用其独特专利组合的权利,该专利组合还在不断增长。

At the same time, the company continues the development of additional algorithms and features that will reach users automatically through periodic version updates and continues the story of follow-up products, SleepX PRO and DreamIT PRO, for the diagnosis and treatment of sleep apnea.

同时,该公司继续开发其他算法和功能,这些算法和功能将通过定期的版本更新自动提供给用户,并延续了用于诊断和治疗睡眠呼吸暂停的后续产品SleepX PRO和DreamIt PRO的故事。

Legal Notice Regarding Forward-Looking Statements

关于前瞻性陈述的法律声明

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, timing of product development, FDA approval/clearance of products in development, customer acceptance of our products in the market, the introduction of competitive products, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the S-1 resale registration statement filed with the Securities and Exchange Commission. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

本新闻稿中包含的声明本质上不是历史性的,是根据1995年《私人证券诉讼改革法》的安全港条款发表的前瞻性陈述。与AppYea未来表现相关的声明受许多因素的影响,包括但不限于充足或营运资金以及我们筹集开发工作所需资金的能力、产品开发的时机、FDA对开发产品的批准/批准、客户对我们产品在市场的接受度、竞争产品的推出、任何产品责任或其他不利诉讼的影响、商业化和技术困难以及S-1中确定的其他风险转售向证券交易委员会提交的注册声明。此类陈述基于管理层当前的信念和期望,存在重大风险和不确定性。实际结果可能与前瞻性陈述中列出的结果有所不同。本新闻稿中包含的前瞻性陈述自发布之日起作出,我们没有义务更新任何前瞻性陈述,无论是由于未来事件、新信息还是其他原因。

Contact:

联系人:


(800) 674-3561
info@appyea.com


(800) 674-3561
info@appyea.com

SOURCE: APPYEA, Inc.

来源: APPYEA, Inc.


View source version on accesswire.com:
在 accesswire.com 上查看源代码版本:

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发